Rare Disease:Targeting Immunology for Hereditary Angioedema and Neurology for Multiple Sclerosis in key Clinical Academic Centers throughout NYC.NJ. PA

Clinical Account Manager for promotion of ultra-orphan drug Cholbam, the first FDA-approved treatment for Bile Acid Synthesis Disorders and Peroxisomal Disorders, including Zellweger Spectrum Disorders. Targets include Academic Institutions-Centers of Excellence, Pediatric Hepatologists & Gastroenterologists, Geneticists, and Opthamologists within within NY, NJ and PA .

Rare Disease Specialist with commercial startup for the launch of RELIZORB, a 1st in class product that addresses fat malabsorption common in serious and rare diseases such as Cystic Fibrosis (Pediatric & Adult) and Digestive Cancers. Targets include Transplant, CF Treatment Centers, Pancreas Oncology Centers, and Academic Hospitals. Driving revenue in a complex selling environment that requires identifying high potential customers with the right patient type, executing thorough total account calls, and navigating customers through a specialty HUB and patient access program.

Successful promotion and launch of novel FNA Nitinol Biopsy Needle to Interventional Pulmonologists, Thoracic Surgeons and Oncology Specialists with start up company. Identified and created customer base for new territory. Developed and maintained relationships in key accounts through clinical consultative sales approach leading to new patients and significant sales increases.

Increased Sales Volume in Cystic Fibrosis Treatment Centers-Pediatric & Adult, Teaching Institutions,Transplant Department. Transformed mediocre territory performance to multiple award winning geography by implementing strategic sales approach, executing "out-of-the-box" tactics, and driving momentum with call progression plan. Successful new product launch of TOBI PodHaler for Cystic Fibrosis involving HUB /SP reimbursement navigation.

Lead and managed 10 sales representatives within 12 state geography whilesuccessfully launching AndroGel resulting in 121% and 136% of sales goals. Hired, Trained, and coached regional sales team with high retention rate and successful sales performance within individual territories.

-Dominated market with Marinol, and Anadrol sales with Oncologists, Endocrinologists, ID Specialists, & Key Teaching Institutions, including UCSF, SF General Research Center, -Establish retrospective clinical chart review program for improvement data results-Organized local Cable TV program for patient broadcast in disease state management